[Webinar] Pancreatic Neuroendocrine Tumors (PNETs) | Pancreatic Cancer Action Network

This webinar discusses treatment approaches and highlights research developments for pancreatic neuroendocrine tumors (PNETs).

Thank you to our webinar sponsor: Ipsen.

Thank you to our Scientific & Medical Affairs Industry Members: AbbVie, AstraZeneca, Rafael, AngioDynamics, Halozyme, Ispen, Janssen Oncology, TriSalus and TYME.

PRESENTER: Eric H. Liu, MD – Rocky Mountain Cancer Centers

################

Do you know someone diagnosed with pancreatic cancer? Direct them to Patient Central for information, resources and hope. Call 877-2-PANCAN, email [email protected] or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT.

################

CONNECT WITH US

WEBSITE: http://pcan.at/PC
FACEBOOK: http://facebook.com/JoinTheFight
TWITTER: http://twitter.com/pancan
INSTAGRAM: http://instagram.com/pancan
YOUTUBE: https://youtube.com/StopPancreaticCancer
and MORE: http://pancan.org/social-media

################

ABOUT PANCREATIC CANCER ACTION NETWORK
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival.